|
|
 |
|
Viewing report
|
|
 |
 |
Market Dynamics: HIV - Combating a Market Slowdown
Datamonitor, Oct 2003, Pages: 136
Introduction: The introduction of structured treatment interruptions and delayed onset to treatment is expected to result in a gradual decline in HIV market growth during the next 5-7 years. As treatment strategies become more complex, physicians will turn towards pharmaceutical companies for drugs with simpler dosing profiles. This In-Depth Commercial Analysis provides a thorough review of current drug use, Swot analyses of marketed products, and a discussion of the life cycle of a typical HIV therapeutic.
Scope: * Global sales data for all currently marketed drugs, with estimates for 2002 revenue
* Forecasts of drug sales for all currently marketed drugs through to 2010
* Swot analyses for all currently marketed drugs
* Analysis of life cycle management of HIV drugs
* Discussion of the impact of generic competition on the HIV market, through comparisons with the oncology market
Report Highlights: Market impacts, such as the introduction of structured treatment interruptions (STIs) and delayed onset to treatment, will cause a gradual decline in HIV market growth during the next 5-7 years
Datamonitor believes that revenues of branded products within the developed world will not be significantly affected by generic competition through to 2010
Reasons to Purchase: * Identify which antiretroviral drug classes have the potential to show the greatest market growth to 2010
* Predict the impact of generics on the antiretroviral markets, as the current market leading products lose patent protection
* Understand how the simplification of therapy regimens and the need to reduce drug-associated side effects will drive development of novel products
* Target the patient segments with the greatest unmet needs
Customers who bought this item also bought
Commercial Insight: HIV - Reshaping Treatment Paradigms
The Global HIV/AIDS Market Outlook to 2012
HIV: Future Treatment Directions - A Strategic Analysis of Market Developments and Opportunities
Pipeline Insight: HIV - The Age of Convenience
Forecast Insight: HIV - Cross-class fixed dose combinations drive continued growth
Global HIV Market: An Analysis
The World Market for Butadiene Rubber (BR): A 2009 Global Trade Perspective
The 2009 Import and Export Market for Butadiene Rubber (BR) in Iran
The 2009 Import and Export Market for Butadiene Rubber (BR) in Belarus
The 2009 Import and Export Market for Butadiene Rubber (BR) in Bulgaria
The 2009 Import and Export Market for Butadiene Rubber (BR) in Colombia
The 2009 Import and Export Market for Butadiene Rubber (BR) in Estonia
|
 |
|
|